PDF) Pregnancy outcome in patients with -thalassemia intermedia at two tertiary care centers, in Beirut and Milan | Mohammed Naja - Academia.edu
Haematologica, Volume 102, issue 12 by Haematologica - Issuu
Cancers | Free Full-Text | Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia?
Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective | Haematologica
Haematologica, Volume 107, Issue 7 by Haematologica - Issuu
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica
PDF) Cure for thalassemia major – From allogeneic hematopoietic stem cell transplantation to gene therapy
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica
Untitled
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? | Haematologica
Untitled
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
Haematologica, Volume 106, Issue 5 by Haematologica - Issuu
Haematologica, Volume 105, Issue 7 by Haematologica - Issuu
Untitled
Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective | Haematologica
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-thalassemia | Haematologica
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-thalassemia | Haematologica
Sickle cell disease is a global prototype for integrative research and healthcare - Royal - 2021 - Advanced Genetics - Wiley Online Library
Haematologica, Volume 107, Issue 11 by Haematologica - Issuu
Haematologica, Volume 106, Issue 9 by Haematologica - Issuu
Haematologica, Volume 104, Issue 4 by Haematologica - Issuu
